1
|
Alexander-Savino CV, Mirowski GW, Culton DA. Mucocutaneous Manifestations of Recreational Drug Use. Am J Clin Dermatol 2024; 25:281-297. [PMID: 38217568 DOI: 10.1007/s40257-023-00835-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2023] [Indexed: 01/15/2024]
Abstract
Recreational drug use is increasingly common in the dermatology patient population and is often associated with both general and specific mucocutaneous manifestations. Signs of substance use disorder may include changes to general appearance, skin, and mucosal findings associated with particular routes of drug administration (injection, insufflation, or inhalation) or findings specific to a particular drug. In this review article, we provide an overview of the mucocutaneous manifestations of illicit drug use including cocaine, methamphetamine, heroin, hallucinogens, marijuana, and common adulterants to facilitate the identification and improved care of these patients with the goal being to connect this patient population with appropriate resources for treatment.
Collapse
Affiliation(s)
- Carolina V Alexander-Savino
- State University of New York Upstate Medical University, Syracuse, NY, USA
- Department of Dermatology, University of North Carolina at Chapel Hill, 410 Market Street, Suite 400, Chapel Hill, NC, 27516, USA
| | - Ginat W Mirowski
- Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA
- Department of Oral Pathology, Medicine, Radiology, Indiana University School of Dentistry, Indianapolis, IN, USA
| | - Donna A Culton
- Department of Dermatology, University of North Carolina at Chapel Hill, 410 Market Street, Suite 400, Chapel Hill, NC, 27516, USA.
| |
Collapse
|
2
|
Balali-Mood M, Sinclair RD, Darchini-Maragheh E, Etemad L. Mucocutaneous alterations and complications in amphetamine abusers: a narrative review. Cutan Ocul Toxicol 2023; 42:219-231. [PMID: 37450708 DOI: 10.1080/15569527.2023.2235425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Revised: 07/04/2023] [Accepted: 07/07/2023] [Indexed: 07/18/2023]
Abstract
Amphetamines are the second most commonly used illicit drug worldwide. Amphetamine use can result in significant cutaneous morbidity. This review highlights the dermatological manifestations of amphetamine abuse.
Collapse
Affiliation(s)
- Mahdi Balali-Mood
- Medical Toxicology and Drug Abuse Research Center, Birjand University of Medical Sciences, Birjand, Iran
| | - Rodney D Sinclair
- Department of Medicine, University of Melbourne, Parkville, Victoria, Australia
- Sinclair Dermatology, Melbourne, Australia
| | - Emadodin Darchini-Maragheh
- Department of Medicine, University of Melbourne, Parkville, Victoria, Australia
- Sinclair Dermatology, Melbourne, Australia
| | - Leila Etemad
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Drug Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|
3
|
Chesivoir EK, Valle S, Grant JE. Comorbid trichotillomania and attention-deficit hyperactivity disorder in adults. Compr Psychiatry 2022; 116:152317. [PMID: 35512574 DOI: 10.1016/j.comppsych.2022.152317] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2022] [Revised: 03/28/2022] [Accepted: 04/19/2022] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Individuals with trichotillomania (TTM), a disorder characterized by repetitive pulling out of one's own hair, often have co-occurring ADHD, but little is known about this comorbidity. Additionally, there have been intimations in the literature that treatment of ADHD with stimulants may worsen TTM symptoms. This study aims to examine clinical aspects of individuals with TTM and co-occurring ADHD. METHODS 308 adults with a current diagnosis of TTM were assessed for ADHD using the Mini International Neuropsychiatric Interview 7.0.2 and Adult ADHD Self Report Scale. Participants also completed clinical measures related to TTM severity, impulsivity, quality of life, and psychosocial dysfunction. A series of analyses of variance were used to calculate differences in scale scores among subjects with and without co-occurring ADHD. RESULTS Of the 308 participants, 47 (15.3%) met the clinical threshold for ADHD. Participants with ADHD reported significantly higher scores in all first and second factor traits of impulsivity, including attentional impulsiveness (p < .0001), motor impulsiveness (p < .0001), and non-planning impulsiveness (p < .0001). Interestingly, participants with ADHD did not report significant differences in TTM severity, perceived quality of life, or functional impairment, regardless of medication status. DISCUSSION The data suggest that ADHD is common in adults with TTM, and the comorbidity is associated with heightened impulsivity. The co-occurrence of ADHD does not affect individuals' quality of life, symptom severity, or functionality. Taking stimulant medications for ADHD also did not appear to affect TTM severity, despite past case reports suggesting these medications may lead to onset or worsening of TTM.
Collapse
Affiliation(s)
- Eve K Chesivoir
- Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA
| | - Stephanie Valle
- Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA
| | - Jon E Grant
- Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Pritzker School of Medicine, Chicago, IL, USA.
| |
Collapse
|
4
|
Moattari CR, França K. Psychokutane Nebenwirkungen bei Konsum und Missbrauch verschreibungspflichtiger Stimulanzien: Eine systematische Übersicht. J Dtsch Dermatol Ges 2022; 20:7-18. [PMID: 35040561 DOI: 10.1111/ddg.14669_g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2021] [Accepted: 10/10/2021] [Indexed: 12/01/2022]
Affiliation(s)
- Cameron R Moattari
- State University of New York Downstate Health Sciences University, College of Medicine, Brooklyn, New York, USA
| | - Katlein França
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Department of Psychiatry and Behavioral Sciences, Institute for Bioethics and Health Policy, University of Miami Miller School of Medicine, Miami, FL, USA
| |
Collapse
|
5
|
Moattari CR, França K. Adverse psychocutaneous effects of prescription stimulant use and abuse: A systematic review. J Dtsch Dermatol Ges 2022; 20:7-15. [PMID: 34990063 DOI: 10.1111/ddg.14669] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2021] [Accepted: 10/10/2021] [Indexed: 11/30/2022]
Abstract
Although rare, psychocutaneous disorders induced by prescription stimulants have been reported throughout the literature. A systematic review was conducted to identify all case reports and case series of prescription stimulant-induced trichotillomania, tactile hallucinations, and delusional infestation. A total of 22 case reports were identified and relevant information was analyzed. Patients presenting with trichotillomania and tactile hallucinations induced by prescription stimulants were typically pediatric male patients being treated for attention deficit hypersensitivity disorder. Symptoms resolved after discontinuation of the offending medication. Patients presenting with delusional infestation secondary to stimulant use or abuse were typically adults who were misusing or abusing stimulant medication. Although symptoms typically improved or resolved after decreasing or discontinuing medication, several patients required the use of antipsychotic medication. While the observational nature of case reports and small number of patients limits meaningful analysis of trends and comparison, this study demonstrates that physicians, especially dermatologists and psychiatrists, should be aware of the potential for prescription stimulants to precipitate adverse psychocutaneous disorders in a minority of individuals.
Collapse
Affiliation(s)
- Cameron R Moattari
- State University of New York Downstate Health Sciences University, College of Medicine, Brooklyn, New York, USA
| | - Katlein França
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Department of Psychiatry and Behavioral Sciences, Institute for Bioethics and Health Policy, University of Miami Miller School of Medicine, Miami, FL, USA
| |
Collapse
|
6
|
Ayaydın H. Probable emergence of symptoms of trichotillomania by atomoxetine: a case report. PSYCHIAT CLIN PSYCH 2019. [DOI: 10.1080/24750573.2018.1439601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Affiliation(s)
- Hamza Ayaydın
- Department of Child and Adolescent Psychiatry, Faculty of Medicine, Harran University, Urfa, Turkey
| |
Collapse
|
7
|
Grall-Bronnec M, Challet-Bouju G, Leboucher J, Fève JM, Le Moigne M, Derkinderen P, Victorri-Vigneau C. Hair-pulling disorder complicated by skin-picking disorder: An unknown side-effect of dopamine replacement therapy? Psychiatry Clin Neurosci 2018; 72:801-802. [PMID: 30039895 DOI: 10.1111/pcn.12769] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2018] [Revised: 07/03/2018] [Accepted: 07/17/2018] [Indexed: 11/30/2022]
Affiliation(s)
- Marie Grall-Bronnec
- Addictology and Psychiatry Department, University Hospital Nantes, Nantes, France.,INSERM Unit U1246, University of Nantes, University of Tours, Nantes, France
| | - Gaëlle Challet-Bouju
- Addictology and Psychiatry Department, University Hospital Nantes, Nantes, France.,INSERM Unit U1246, University of Nantes, University of Tours, Nantes, France
| | - Juliette Leboucher
- Addictology and Psychiatry Department, University Hospital Nantes, Nantes, France
| | - Jean-Marc Fève
- Neurology Department, Jules Verne Clinic, Nantes, France
| | - Marie Le Moigne
- INSERM Unit U1246, University of Nantes, University of Tours, Nantes, France.,Dermatology Department, University Hospital Nantes, Nantes, France
| | - Pascal Derkinderen
- Neurology Department, University Hospital Nantes, Nantes, France.,INSERM Unit U913, University of Nantes, Nantes, France
| | - Caroline Victorri-Vigneau
- INSERM Unit U1246, University of Nantes, University of Tours, Nantes, France.,Pharmacology Department, University Hospital Nantes, Nantes, France
| |
Collapse
|
8
|
|
9
|
Gunes S. Modified-Release Methylphenidate-Related Trichotillomania in a Boy with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol 2017; 27:675-676. [PMID: 28394174 DOI: 10.1089/cap.2017.0001] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Serkan Gunes
- Department of Child and Adolescent Psychiatry, Hatay State Hospital , Hatay, Turkey
| |
Collapse
|
10
|
|
11
|
|